Brandon Mahal, MD
Radiation Oncology · Miami, FLNPI 1861874141
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Pfizer accounts for 80.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $16,225 and has fallen 98.2% since, to $291 in 2025. Among radiation oncology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $894.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$22K
- Myovant Sciences Inc.$3K
- Johnson & Johnson$1K
- Sanofi$687
- Progenics Pharmaceuticals, Inc.$151
- Astellas Pharma US Inc$70
- plus $36 from 1 others
What the payments were for
- Consulting fees$8,67231%
- Speaking & faculty fees$16,17058%
- Travel & lodging$4332%
- Food & beverage$2,4429%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $22,223 |
| Myovant Sciences Inc. | 2 | $3,120 |
| Johnson & Johnson | 1 | $1,430 |
| Sanofi | 4 | $687 |
| Progenics Pharmaceuticals, Inc. | 1 | $151 |
| Astellas Pharma US Inc | 1 | $70 |
| Boston Scientific | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,717 in reported general payments places this provider in the 90th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 50 | $396 |
| Sildenafil Citrate | 11 | $153 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Miami
- Marcio FagundesMiami$274K
- Rupesh KotechaMiami$208K
- Michael ChuongMiami$152K
- Marcus BredelMiami$64K
- Minesh MehtaMiami$38K
- Matthew AbramowitzMiami$23K
- Ana BoteroMiami$21K
- Alan Dal PraMiami$10K
- Ahmed AklMiami$8K
- Shravan KandulaOrlando$444K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.